Accelerate therapy starts through connected workflows

When specialty pharmacies don't have complete patient data, they lose time chasing details—and patients wait longer to start treatment. By enabling shared workflows that connect prescribers, payers and pharmacies, the right information reaches specialty pharmacies sooner—easing administrative burden and helping patients start therapy faster.

PatientHistory MissingInformation LtBlue
Key challenges

Delays in therapy initiation from fragmented workflows

Admin burdens driving frustration & burnout

Missing or incomplete patient information delaying treatment

Data Transfer Lt Blue
How we help

Secure, in-workflow communication replacing manual outreach

Trusted clinical & eligibility intelligence within pharmacy workflows

Automatically enhanced & validated prescription data

Giving Assistance LtBlue
Outcomes

Shorter time to fill & faster therapy initiation

Less administrative burden & more time for patients

Confident prescription fulfillment & faster vital treatment starts

Solutions

Get insights to expedite therapy

Every step in the specialty fulfillment journey matters—and so does having the right information at the right moment. With a single, trusted connection, specialty pharmacies gain the insights needed to coordinate across stakeholders, reduce friction and move patients to therapy faster.

Put trusted intelligence to work for you and the patients you serve

Connect with our team to explore how we can partner to increase patient safety, reduce costs and ensure quality care. 

Success Stories

Real-world results

“Surescripts solutions accelerate the process for specialty prescribing, fulfillment and onboarding by filling information gaps with clinical intelligence. Speed and patient safety are enhanced.”

Katie Reeves Senior Product Manager, Accredo

“Walgreens works with Surescripts because we share the goals of wanting to improve patient care and health outcomes.”

Khadijah Khan Manager, Clinical Pharmacy Strategy (Neurology, Organ Transplant), Walgreens
Why Surescripts

Expertise that supports your goals

Satisfaction Guaranteed LtBlue
Proven track record

Surescripts is known for high-quality implementations and ensuring customer success.

Collaboration Huddle Lt Blue
Network Alliance Partner Program

We’ll partner with you to develop powerful materials that influence adoption and best practices. 

Profile LtBlue
Promoting safe, efficient prescriptions

We’re optimizing performance to improve prescription accuracy industrywide. 

Insights

Keep pace with healthcare innovation

FAQs

Find out more about how we help specialty pharmacies

What challenges do specialty pharmacies face that Surescripts can help address?

Specialty pharmacies often face complex fulfillment processes, and missing information leads to delays and increased administrative burden. Surescripts brings insights that expedite therapy, helping pharmacists fill prescriptions confidently and quickly.

How does Surescripts support specialty pharmacy operations?

Surescripts provides trusted health intelligence that helps specialty pharmacies access benefit and coverage information, streamline communication with prescribers and reduce manual work related to benefit investigation and authorization workflows.

How does improved interoperability benefit specialty pharmacies?

Surescripts brings specialty pharmacies comprehensive clinical and eligibility data from providers and payers, supporting timely prescription fulfillment, care continuity and fewer manual outreach steps.

What value does Surescripts network connectivity provide specialty pharmacies?

Connectivity within a broad, secure network streamlines information exchange between specialty pharmacies, prescribers and payers. This reduces reliance on phone and fax workflows, enables more efficient data sharing and helps ensure that critical medication and coverage details are communicated accurately.

References
  1. Surescripts, “2025 Annual Impact Report,” p. 8.
  2. Surescripts, “2025 Annual Impact Report,” p. 11.
  3. Surescripts, “2025 Annual Impact Report,” p. 7.
Read more